Mutational Profile of Oropharyngeal Squamous Cell Carcinoma in Relation to HPV : Comparison of Taiwan Data With Published Studies
Oral Diseases · 2026-11-09
DOI: 10.1111/odi.70574 ↗Abstract
ABSTRACT Background To descriptively compare genomic profiles by human papillomavirus (HPV) status in a Taiwanese multicenter registry with published Western cohorts. Methods We reviewed aggregate findings from 290 OPSCC cases in TCOG T1322 (ACTOnco + 440‐gene panel) and selected studies from the United States and Europe. No formal cross‐cohort statistical comparison was performed. Results and Discussion Major driver‐gene patterns were broadly similar across cohorts. In the T1322 TMB‐evaluable subset (HPV‐positive n = 187; HPV‐negative n = 99), the supplied summary reported a median TMB of 3.2 mutations/Mb in both groups, with interquartile ranges of 1.3–5.7 and 1.9–4.4 mutations/Mb, respectively. A verified p value for this updated subset was unavailable; therefore, no inference about statistical significance is made. Conclusion Cross‐study patterns are hypothesis‐generating, and quantitative biomarker comparisons require harmonized methodology and independent validation.
EUVIMED